The Newsroom

Investigations  /  11.25.2019

Shareholder Investigation of Sage Therapeutics

Robbins LLP is Investigating the Officers and Directors of Sage Therapeutics, Inc. (SAGE) on behalf of Shareholders

We are investigating whether certain officers and directors of Sage Therapeutics, Inc. breached their fiduciary duties to shareholders. Sage Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes medicines to treat central nervous system (CNS) disorders.

Sage Therapeutics, Inc. (SAGE) Shareholders Have Legal Options

Concerned shareholders of Sage Therapeutics, Inc. (SAGE) who would like more information about your rights and potential remedies can send us a message via the Shareholder Information Form below.

Shareholder Information

  • Please Note: Neither the submission to nor the receipt of information by Robbins LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns